Differences between revisions 2 and 3
Revision 2 as of 2006-11-17 15:48:06
Size: 2577
Editor: lfrq80
Comment: Reorganizing the MIM pages
Revision 3 as of 2006-11-17 21:21:28
Size: 2583
Editor: lfrq80
Comment:
Deletions are marked like this. Additions are marked like this.
Line 8: Line 8:
|| '''Use Case Name''' : EditAnnotation || || '''Use Case Name''' : ../EditAnnotation ||
Line 48: Line 48:
Shared MimEditorUseCaseComments Shared ../MimEditorUseCaseComments

Use Case Name : ../EditAnnotation

For Feature : MIMEditor

Editors: DavidKane

TableOfContents([2])

Summary

A user wants to add or edit annotations to a feature in a map.

Step-by-Step User Action

  1. User selects feature in the map
  2. User specifies that the feature’s annotations should be edited
  3. User adds a pubmed id, or other reference as evidence for the presence of the feature in the map

Visual Aides

Requirements for Cytoscape

TBD

Importance

Annotations are very important for the credibility of maps that seek wide usage. However, the process of adding annotations should not be tightly coupled to the process of creating and editing the map. So the process of adding annotations needs to be able to happen afterwards.

Other Examples

Comments

Shared ../MimEditorUseCaseComments

PageComment2

Molecular_Interaction_Maps/EditAnnotation (last edited 2009-02-12 01:03:15 by localhost)

Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the Na tional Institutes of Health (NIH) under award number GM070743-01. Corporate funding is provided through a contract from Unilever PLC.

MoinMoin Appliance - Powered by TurnKey Linux